391 related articles for article (PubMed ID: 26414086)
1. Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.
van der Garde M; van Pel M; Millán Rivero JE; de Graaf-Dijkstra A; Slot MC; Kleinveld Y; Watt SM; Roelofs H; Zwaginga JJ
Stem Cells Dev; 2015 Nov; 24(22):2649-59. PubMed ID: 26414086
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
[TBL] [Abstract][Full Text] [Related]
4. No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.
van der Garde M; Brand A; Slot MC; de Graaf-Dijkstra A; Zwaginga JJ; van Hensbergen Y
Stem Cells Dev; 2015 Jun; 24(12):1448-56. PubMed ID: 25668618
[TBL] [Abstract][Full Text] [Related]
5. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
[TBL] [Abstract][Full Text] [Related]
6. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
[TBL] [Abstract][Full Text] [Related]
7. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
[TBL] [Abstract][Full Text] [Related]
8. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice.
Hiwase SD; Dyson PG; To LB; Lewis ID
Stem Cells; 2009 Sep; 27(9):2293-300. PubMed ID: 19544531
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
[TBL] [Abstract][Full Text] [Related]
10. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
[TBL] [Abstract][Full Text] [Related]
11. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.
Bakhshi T; Zabriskie RC; Bodie S; Kidd S; Ramin S; Paganessi LA; Gregory SA; Fung HC; Christopherson KW
Transfusion; 2008 Dec; 48(12):2638-44. PubMed ID: 18798803
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow.
Klein C; Strobel J; Zingsem J; Richter RH; Goecke TW; Beckmann MW; Eckstein R; Weisbach V
Tissue Eng Part A; 2013 Dec; 19(23-24):2577-85. PubMed ID: 24308543
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
15. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of mesenchymal stromal cells derived from rabbit bone marrow and Wharton's jelly for adipose tissue engineering.
Li L; Dong J; He Y; Mao W; Tang H; Dong Y; Lyu F
Connect Tissue Res; 2020 Nov; 61(6):537-545. PubMed ID: 31185754
[No Abstract] [Full Text] [Related]
17. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
[TBL] [Abstract][Full Text] [Related]
18. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
[TBL] [Abstract][Full Text] [Related]
19. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
